Dr. Reddy’s Laboratories Ltd. announced the release of Difluprednate Ophthalmic Emulsion 0.05%.
This medication is used to alleviate swelling and pain associated with eye surgery. It may also be used to treat a serious eye condition. This medication belongs to the corticosteroid class of drugs.
According to Dr. Reddy’s Labs, it is a therapeutic generic equivalent to Durezol (Difluprednate Ophthalmic Emulsion 0.05%) in the United States market, following FDA approval (USFDA). According to IQVIA, the Durezol brand and generic had U.S. sales of approximately $40 million MAT in the most recent twelve months ending in November 2022. Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05% is available in case packs of 24 5 ml bottles.